Industry Research Reports

Home > Reports > Pharma & Healthcare > Celecoxib API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Celecoxib API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-18

Pages: 133 Pages

Report ld: 2326663

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.

The global market for Celecoxib API was estimated to be worth US$ 56 million in 2023 and is forecast to a readjusted size of US$ 82 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Celecoxib API Market Size

M= millions and B=billions

Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately. 
Report Scope
This report aims to provide a comprehensive presentation of the global market for Celecoxib API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Celecoxib API by region & country, by Type, and by Application.

The Celecoxib API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celecoxib API.

Market Segmentation

Report Metric
Details
Report Title
Celecoxib API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 82 million
CAGR(2024-2030)
4.9%
Market Size Available for Years
2019-2030
Global Celecoxib API Companies Covered
Pfizer, Teva Pharmaceuticals, Viatris(Mylan), ScinoPharm, Jiangxi Synergy, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, Hisun Pharmaceutical Nantong, Aurobindo Pharma, Punjab Chemicals
Global Celecoxib API Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Celecoxib API Market, Segment by Type
Standard grade Celecoxib API

Micronized Celecoxib API
Global Celecoxib API Market, Segment by Application
Pharmaceutical

Laboratory
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Celecoxib API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Celecoxib API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Celecoxib API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Celecoxib API Product Introduction
    1.2 Global Celecoxib API Market Size Forecast
        1.2.1 Global Celecoxib API Sales Value (2019-2030)
        1.2.2 Global Celecoxib API Sales Volume (2019-2030)
        1.2.3 Global Celecoxib API Sales Price (2019-2030)
    1.3 Celecoxib API Market Trends & Drivers
        1.3.1 Celecoxib API Industry Trends
        1.3.2 Celecoxib API Market Drivers & Opportunity
        1.3.3 Celecoxib API Market Challenges
        1.3.4 Celecoxib API Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Celecoxib API Players Revenue Ranking (2023)
    2.2 Global Celecoxib API Revenue by Company (2019-2024)
    2.3 Global Celecoxib API Players Sales Volume Ranking (2023)
    2.4 Global Celecoxib API Sales Volume by Company Players (2019-2024)
    2.5 Global Celecoxib API Average Price by Company (2019-2024)
    2.6 Key Manufacturers Celecoxib API Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Celecoxib API Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Celecoxib API
    2.9 Celecoxib API Market Competitive Analysis
        2.9.1 Celecoxib API Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Celecoxib API Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib API as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Standard grade Celecoxib API
        3.1.2 Micronized Celecoxib API
    3.2 Global Celecoxib API Sales Value by Type
        3.2.1 Global Celecoxib API Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Celecoxib API Sales Value, by Type (2019-2030)
        3.2.3 Global Celecoxib API Sales Value, by Type (%) (2019-2030)
    3.3 Global Celecoxib API Sales Volume by Type
        3.3.1 Global Celecoxib API Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Celecoxib API Sales Volume, by Type (2019-2030)
        3.3.3 Global Celecoxib API Sales Volume, by Type (%) (2019-2030)
    3.4 Global Celecoxib API Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pharmaceutical
        4.1.2 Laboratory
    4.2 Global Celecoxib API Sales Value by Application
        4.2.1 Global Celecoxib API Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Celecoxib API Sales Value, by Application (2019-2030)
        4.2.3 Global Celecoxib API Sales Value, by Application (%) (2019-2030)
    4.3 Global Celecoxib API Sales Volume by Application
        4.3.1 Global Celecoxib API Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Celecoxib API Sales Volume, by Application (2019-2030)
        4.3.3 Global Celecoxib API Sales Volume, by Application (%) (2019-2030)
    4.4 Global Celecoxib API Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Celecoxib API Sales Value by Region
        5.1.1 Global Celecoxib API Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Celecoxib API Sales Value by Region (2019-2024)
        5.1.3 Global Celecoxib API Sales Value by Region (2025-2030)
        5.1.4 Global Celecoxib API Sales Value by Region (%), (2019-2030)
    5.2 Global Celecoxib API Sales Volume by Region
        5.2.1 Global Celecoxib API Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Celecoxib API Sales Volume by Region (2019-2024)
        5.2.3 Global Celecoxib API Sales Volume by Region (2025-2030)
        5.2.4 Global Celecoxib API Sales Volume by Region (%), (2019-2030)
    5.3 Global Celecoxib API Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Celecoxib API Sales Value, 2019-2030
        5.4.2 North America Celecoxib API Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Celecoxib API Sales Value, 2019-2030
        5.5.2 Europe Celecoxib API Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Celecoxib API Sales Value, 2019-2030
        5.6.2 Asia Pacific Celecoxib API Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Celecoxib API Sales Value, 2019-2030
        5.7.2 South America Celecoxib API Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Celecoxib API Sales Value, 2019-2030
        5.8.2 Middle East & Africa Celecoxib API Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Celecoxib API Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Celecoxib API Sales Value
        6.2.1 Key Countries/Regions Celecoxib API Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Celecoxib API Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Celecoxib API Sales Value, 2019-2030
        6.3.2 United States Celecoxib API Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Celecoxib API Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Celecoxib API Sales Value, 2019-2030
        6.4.2 Europe Celecoxib API Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Celecoxib API Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Celecoxib API Sales Value, 2019-2030
        6.5.2 China Celecoxib API Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Celecoxib API Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Celecoxib API Sales Value, 2019-2030
        6.6.2 Japan Celecoxib API Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Celecoxib API Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Celecoxib API Sales Value, 2019-2030
        6.7.2 South Korea Celecoxib API Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Celecoxib API Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Celecoxib API Sales Value, 2019-2030
        6.8.2 Southeast Asia Celecoxib API Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Celecoxib API Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Celecoxib API Sales Value, 2019-2030
        6.9.2 India Celecoxib API Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Celecoxib API Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Information
        7.1.2 Pfizer Introduction and Business Overview
        7.1.3 Pfizer Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Pfizer Celecoxib API Product Offerings
        7.1.5 Pfizer Recent Development
    7.2 Teva Pharmaceuticals
        7.2.1 Teva Pharmaceuticals Company Information
        7.2.2 Teva Pharmaceuticals Introduction and Business Overview
        7.2.3 Teva Pharmaceuticals Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Teva Pharmaceuticals Celecoxib API Product Offerings
        7.2.5 Teva Pharmaceuticals Recent Development
    7.3 Viatris(Mylan)
        7.3.1 Viatris(Mylan) Company Information
        7.3.2 Viatris(Mylan) Introduction and Business Overview
        7.3.3 Viatris(Mylan) Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Viatris(Mylan) Celecoxib API Product Offerings
        7.3.5 Viatris(Mylan) Recent Development
    7.4 ScinoPharm
        7.4.1 ScinoPharm Company Information
        7.4.2 ScinoPharm Introduction and Business Overview
        7.4.3 ScinoPharm Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 ScinoPharm Celecoxib API Product Offerings
        7.4.5 ScinoPharm Recent Development
    7.5 Jiangxi Synergy
        7.5.1 Jiangxi Synergy Company Information
        7.5.2 Jiangxi Synergy Introduction and Business Overview
        7.5.3 Jiangxi Synergy Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Jiangxi Synergy Celecoxib API Product Offerings
        7.5.5 Jiangxi Synergy Recent Development
    7.6 Jiangsu Hengrui Medicine
        7.6.1 Jiangsu Hengrui Medicine Company Information
        7.6.2 Jiangsu Hengrui Medicine Introduction and Business Overview
        7.6.3 Jiangsu Hengrui Medicine Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Jiangsu Hengrui Medicine Celecoxib API Product Offerings
        7.6.5 Jiangsu Hengrui Medicine Recent Development
    7.7 Jiangsu Chiatai Qingjiang
        7.7.1 Jiangsu Chiatai Qingjiang Company Information
        7.7.2 Jiangsu Chiatai Qingjiang Introduction and Business Overview
        7.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Jiangsu Chiatai Qingjiang Celecoxib API Product Offerings
        7.7.5 Jiangsu Chiatai Qingjiang Recent Development
    7.8 Hisun Pharmaceutical Nantong
        7.8.1 Hisun Pharmaceutical Nantong Company Information
        7.8.2 Hisun Pharmaceutical Nantong Introduction and Business Overview
        7.8.3 Hisun Pharmaceutical Nantong Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Hisun Pharmaceutical Nantong Celecoxib API Product Offerings
        7.8.5 Hisun Pharmaceutical Nantong Recent Development
    7.9 Aurobindo Pharma
        7.9.1 Aurobindo Pharma Company Information
        7.9.2 Aurobindo Pharma Introduction and Business Overview
        7.9.3 Aurobindo Pharma Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Aurobindo Pharma Celecoxib API Product Offerings
        7.9.5 Aurobindo Pharma Recent Development
    7.10 Punjab Chemicals
        7.10.1 Punjab Chemicals Company Information
        7.10.2 Punjab Chemicals Introduction and Business Overview
        7.10.3 Punjab Chemicals Celecoxib API Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Punjab Chemicals Celecoxib API Product Offerings
        7.10.5 Punjab Chemicals Recent Development

 8 Industry Chain Analysis
    8.1 Celecoxib API Industrial Chain
    8.2 Celecoxib API Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Celecoxib API Sales Model
        8.5.2 Sales Channel
        8.5.3 Celecoxib API Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Celecoxib API Market Trends
    Table 2. Celecoxib API Market Drivers & Opportunity
    Table 3. Celecoxib API Market Challenges
    Table 4. Celecoxib API Market Restraints
    Table 5. Global Celecoxib API Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Celecoxib API Revenue Market Share by Company (2019-2024)
    Table 7. Global Celecoxib API Sales Volume by Company (2019-2024) & (Kg)
    Table 8. Global Celecoxib API Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Celecoxib API Price by Company (2019-2024) & (US$/Kg)
    Table 10. Key Manufacturers Celecoxib API Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Celecoxib API Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Celecoxib API
    Table 13. Global Celecoxib API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib API as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Celecoxib API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Celecoxib API Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Celecoxib API Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Celecoxib API Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Celecoxib API Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Celecoxib API Sales Volume by Type: 2019 VS 2023 VS 2030 (Kg)
    Table 22. Global Celecoxib API Sales Volume by Type (2019-2024) & (Kg)
    Table 23. Global Celecoxib API Sales Volume by Type (2025-2030) & (Kg)
    Table 24. Global Celecoxib API Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Celecoxib API Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Celecoxib API Price by Type (2019-2024) & (US$/Kg)
    Table 27. Global Celecoxib API Price by Type (2025-2030) & (US$/Kg)
    Table 28. Global Celecoxib API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Celecoxib API Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Celecoxib API Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Celecoxib API Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Celecoxib API Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Celecoxib API Sales Volume by Application: 2019 VS 2023 VS 2030 (Kg)
    Table 34. Global Celecoxib API Sales Volume by Application (2019-2024) & (Kg)
    Table 35. Global Celecoxib API Sales Volume by Application (2025-2030) & (Kg)
    Table 36. Global Celecoxib API Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Celecoxib API Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Celecoxib API Price by Application (2019-2024) & (US$/Kg)
    Table 39. Global Celecoxib API Price by Application (2025-2030) & (US$/Kg)
    Table 40. Global Celecoxib API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Celecoxib API Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Celecoxib API Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Celecoxib API Sales Value by Region (2019-2024) & (%)
    Table 44. Global Celecoxib API Sales Value by Region (2025-2030) & (%)
    Table 45. Global Celecoxib API Sales Volume by Region (Kg): 2019 VS 2023 VS 2030
    Table 46. Global Celecoxib API Sales Volume by Region (2019-2024) & (Kg)
    Table 47. Global Celecoxib API Sales Volume by Region (2025-2030) & (Kg)
    Table 48. Global Celecoxib API Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Celecoxib API Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Celecoxib API Average Price by Region (2019-2024) & (US$/Kg)
    Table 51. Global Celecoxib API Average Price by Region (2025-2030) & (US$/Kg)
    Table 52. Key Countries/Regions Celecoxib API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Celecoxib API Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Celecoxib API Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Celecoxib API Sales Volume, (2019-2024) & (Kg)
    Table 56. Key Countries/Regions Celecoxib API Sales Volume, (2025-2030) & (Kg)
    Table 57. Pfizer Company Information
    Table 58. Pfizer Introduction and Business Overview
    Table 59. Pfizer Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 60. Pfizer Celecoxib API Product Offerings
    Table 61. Pfizer Recent Development
    Table 62. Teva Pharmaceuticals Company Information
    Table 63. Teva Pharmaceuticals Introduction and Business Overview
    Table 64. Teva Pharmaceuticals Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 65. Teva Pharmaceuticals Celecoxib API Product Offerings
    Table 66. Teva Pharmaceuticals Recent Development
    Table 67. Viatris(Mylan) Company Information
    Table 68. Viatris(Mylan) Introduction and Business Overview
    Table 69. Viatris(Mylan) Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 70. Viatris(Mylan) Celecoxib API Product Offerings
    Table 71. Viatris(Mylan) Recent Development
    Table 72. ScinoPharm Company Information
    Table 73. ScinoPharm Introduction and Business Overview
    Table 74. ScinoPharm Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 75. ScinoPharm Celecoxib API Product Offerings
    Table 76. ScinoPharm Recent Development
    Table 77. Jiangxi Synergy Company Information
    Table 78. Jiangxi Synergy Introduction and Business Overview
    Table 79. Jiangxi Synergy Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 80. Jiangxi Synergy Celecoxib API Product Offerings
    Table 81. Jiangxi Synergy Recent Development
    Table 82. Jiangsu Hengrui Medicine Company Information
    Table 83. Jiangsu Hengrui Medicine Introduction and Business Overview
    Table 84. Jiangsu Hengrui Medicine Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 85. Jiangsu Hengrui Medicine Celecoxib API Product Offerings
    Table 86. Jiangsu Hengrui Medicine Recent Development
    Table 87. Jiangsu Chiatai Qingjiang Company Information
    Table 88. Jiangsu Chiatai Qingjiang Introduction and Business Overview
    Table 89. Jiangsu Chiatai Qingjiang Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 90. Jiangsu Chiatai Qingjiang Celecoxib API Product Offerings
    Table 91. Jiangsu Chiatai Qingjiang Recent Development
    Table 92. Hisun Pharmaceutical Nantong Company Information
    Table 93. Hisun Pharmaceutical Nantong Introduction and Business Overview
    Table 94. Hisun Pharmaceutical Nantong Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 95. Hisun Pharmaceutical Nantong Celecoxib API Product Offerings
    Table 96. Hisun Pharmaceutical Nantong Recent Development
    Table 97. Aurobindo Pharma Company Information
    Table 98. Aurobindo Pharma Introduction and Business Overview
    Table 99. Aurobindo Pharma Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 100. Aurobindo Pharma Celecoxib API Product Offerings
    Table 101. Aurobindo Pharma Recent Development
    Table 102. Punjab Chemicals Company Information
    Table 103. Punjab Chemicals Introduction and Business Overview
    Table 104. Punjab Chemicals Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 105. Punjab Chemicals Celecoxib API Product Offerings
    Table 106. Punjab Chemicals Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Celecoxib API Downstream Customers
    Table 110. Celecoxib API Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Celecoxib API Product Picture
    Figure 2. Global Celecoxib API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Celecoxib API Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Celecoxib API Sales Volume (2019-2030) & (Kg)
    Figure 5. Global Celecoxib API Sales Price (2019-2030) & (US$/Kg)
    Figure 6. Celecoxib API Report Years Considered
    Figure 7. Global Celecoxib API Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Celecoxib API Players Sales Volume Ranking (2023) & (Kg)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Celecoxib API Revenue in 2023
    Figure 10. Celecoxib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Standard grade Celecoxib API Picture
    Figure 12. Micronized Celecoxib API Picture
    Figure 13. Global Celecoxib API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Celecoxib API Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Celecoxib API Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)
    Figure 16. Global Celecoxib API Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Celecoxib API Price by Type (2019-2030) & (US$/Kg)
    Figure 18. Product Picture of Pharmaceutical
    Figure 19. Product Picture of Laboratory
    Figure 20. Global Celecoxib API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Celecoxib API Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Celecoxib API Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)
    Figure 23. Global Celecoxib API Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Celecoxib API Price by Application (2019-2030) & (US$/Kg)
    Figure 25. North America Celecoxib API Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Celecoxib API Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Celecoxib API Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Celecoxib API Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Celecoxib API Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Celecoxib API Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Celecoxib API Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Celecoxib API Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Celecoxib API Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Celecoxib API Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Celecoxib API Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Celecoxib API Sales Volume (%), (2019-2030)
    Figure 37. United States Celecoxib API Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Celecoxib API Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Celecoxib API Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Celecoxib API Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Celecoxib API Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Celecoxib API Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Celecoxib API Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Celecoxib API Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Celecoxib API Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Celecoxib API Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Celecoxib API Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Celecoxib API Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Celecoxib API Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Celecoxib API Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Celecoxib API Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Celecoxib API Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Celecoxib API Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Celecoxib API Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Celecoxib API Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Celecoxib API Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Celecoxib API Sales Value by Application (%), 2023 VS 2030
    Figure 58. Celecoxib API Industrial Chain
    Figure 59. Celecoxib API Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Description

Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.

The global market for Celecoxib API was estimated to be worth US$ 56 million in 2023 and is forecast to a readjusted size of US$ 82 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately. 
Report Scope
This report aims to provide a comprehensive presentation of the global market for Celecoxib API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Celecoxib API by region & country, by Type, and by Application.

The Celecoxib API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celecoxib API.

Market Segmentation